GlucoSet SIGNED
Microsensor for continuous arterial blood glucose monitoring
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0GlucoSet project word cloud
Explore the words cloud of the GlucoSet project. It provides you a very rough idea of what is the project "GlucoSet" about.
Project "GlucoSet" data sheet
The following table provides information about the project.
| Coordinator |
GLUCOSET AS
Organization address contact info |
| Coordinator Country | Norway [NO] |
| Project website | http://glucoset.com |
| Total cost | 6˙368˙407 € |
| EC max contribution | 2˙376˙150 € (37%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-2 |
| Funding Scheme | SME-2 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-10-01 to 2020-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | GLUCOSET AS | NO (TRONDHEIM) | coordinator | 2˙376˙150.00 |
Map
Project objective
- Poor glucose control in critically ill patients leads to significant increases in costs, complication and mortality rates. Continuous monitoring of glucose will reduce costs of €2700 per patient and could save 58 000 lives in the EU every year.
- GlucoSet has developed a disposable glucose sensor for monitoring glucose in the ICU. The sensor measures glucose by measuring sub-nanometer length changes in an advanced material that responds to the glucose level. The product is designed for mass-manufacturing at its core. The innovative fiber optic sensor is protected by granted patents and has freedom to operate. The sensor will be sold as a single-use device lasting 96h with a gross margin of over 90% at high volume.
- The total addressable market (US and EU) is $1600 million per year. Willingness to pay has already been confirmed. The project has strong backing from key opinion leaders.
- Unlike the competition, the sensor couples to the indwelling arterial catheter, which enables unsurpassed reliability and ease of use.
- The SMEi phase 2 will take the project from working prototypes that have been tested in vivo, to a CE-marked device. We expect market entry in 2021 in the EU.
- The company has a very strong team that has extensive experience with medical devices, scaling up production and raising and working with venture capital.
Deliverables
| Updated website | Websites, patent fillings, videos etc. | 2019-11-12 11:32:48 |
| Data Management Plan – DMP | Documents, reports | 2019-11-12 11:32:45 |
Take a look to the deliverables list in detail: detailed list of GlucoSet deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLUCOSET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GLUCOSET" are provided by the European Opendata Portal: CORDIS opendata.